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The effect of sphingosine (SPH) on the adhesive properties of Lewis lung carcinoma (3LL) cells was investigated using plastic precoated with the 
extracellular matrix proteins, laminin, fibronectin, or type IV collagen. Treatment of 3LL cells with SPH (0.5-10 PM) resulted in a dose-dependent 
decrease in the ability to bind to laminin and type IV collagen but had little or no effect on atachment o fibronectin. Phorbol 12-myristate 13-acetate 
(PMA) selectively enhanced attachment of 3LL cells to laminin and collagen. The inhibitory effect of SPH on attachment o both proteins was 
competitively antagonized by PMA. These results suggest that SPH acts as a negative effector for cell attachment o laminin and collagen, and 
that the ccl: attachment process to both proteins might be regulated in part by protein kinase C. 
Sphingosine; Cell adhesion; Protein kinase C; Laminin; Collagen type IV; Lewis lung carcinoma 
1. INTRODUCTION 
The interaction between basement membrane coin- 
ponents, such as laminin, fibronectin, and collagen, 
and their cell surface receptors may play a key role in 
the mechanism of tumor invasion and metastasis [1 J. In 
animal models, tumor cells selected for their ability to 
attach via laminin produced IO-fold more metastases 
following i.v. injection [a]. Moreover, increased expres- 
sion of laminin and collagen receptors in various cancer 
cells have been associated with increased invasive and 
metastatic potentials [3-61. These results suggest the 
roles of these cell surface receptors in malignancy. In 
our recent work, an inhibitor of UDP-glucose:N- 
acylsphingosine glucosyltransferase (EC 2.4.1.80), D- 
threo-l-phenyl-2-decanoylamino-3-morpholino-l-pro- 
panol (D-PDMP), was found to inhibit the attachment 
of B16 melanoma cells to laminin and type IV collagen, 
but not to fibronectin [7]. Moreover, treatment of 
Lewis lung carcinoma (3LL) cells with D-PDMP 
resulted in significant inhibition of the attachment abili- 
ty to laminin and experimental metastatic potential [8]. 
Since D-PDMP treatment not only blocks all 
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glycosphingolipid synthesis but also induces the ac- 
cumulation of ceramide and sphingoid bases [9], the 
observed effects of D-PDMP might be due to the ac- 
cumulation of these precursors of glucosylceramide. 
Sphingoid bases including sphingosine (SPH) have 
recently attracted considerable attention, primarily 
because - added exogenously to cells - they inhibit the 
activity of the Ca*+/phospholipid-dependent enzyme 
protein kinase C (PKC) and regulate various cellular 
events which depend on its activation [lO,ll]. In the 
present study, we demonstrate that SPH acts as a 
negative effector for cell attachment o laminin and col- 
lagen, and that the cell attachment process to both pro- 
teins might be regulated in part by protein kinase C. 
2. MATERIALS AND METHODS 
2, I. Cells and culrure conditions 
3LL cells were from Dr. T. Taniguchi (Kyushu University, Institute 
of Bioregulation, Fukuoka, Japan). The cells were maintained in 
Roswell Park Memorial Institute (RPMI) Medium 1640 in 10% fetal 
calf serum, penicillin (100 units/ml), and streptomycin (lOOpg/ml) 
(all from Grand Island Biological Co., Grand Island, NY) at 37°C in 
a humidified atmosphere of 51 CO2/9S% air. Staining with Hoechst 
33258 showed all cells to bc free of mycoplasma, To ensure 
reproducibility, we performed all experiments with cultures grown 
<6 weeks after recovery from frozen stocks, 
2.2. Stock ~olitrions of SPH and PMA 
PMA and rru,rs-D-erytliro-SPH ptcpared from bovine brain 
sphingomyclin were from Sigma Chemical Co. (St. Louis, MO). The 
purity of SPH was assessed by TLC (Silica Gel plates) with 
shloroform/mcthanul/7M NHoOH (80:20:2) [U], and the spot was 
visualized by impregnating the plates with a modified charring 
rcagcnt [12], 100 g of CuSO4 - SHZO it1 cont. HjPO&vater/MeOH 
(100/750/400 nil). The sample (100 ~8) yielded a single spot coinci- 
39 
Volume 286, number 1,2 FEBS LETTERS July 1991 
dent with SPH, showing that there was no visible contamination by 
dimethyl-SPH. The stock solution of SPH was prepared as equimolar 
concentrations of SPH and fatty acid free BSA by the method of Mer- 
rill et al. [13] for the purpose of reducing cytotoxicity of SPH [14]. 
The PMA was added as a 1% solution in dimethylsulfoxide. 
2.3. Cell attachment assay 
Mouse laminin, human fibronectin, and type IV collagen were 
from Iwaki Glass Co. (Osaka, Japan). The attachment assay was per- 
formed as described [g] with slight modification. The proteins were 
diluted with PBS and were allowed to bind to ‘X-well polystyrene 
microtiter plates (Flow Laboratories, McLean, VA) overnight at 4°C. 
The wells were then coated further with 1% BSA in PBS for 2 h. Cells 
from the culture flasks were detached by the addition of EDTA to the 
culture medium (2 mg/ml), pelleted, washed, and resuspended at 10’ 
cells/ml in the assay medium (RPM1 1640 containing 0.1% EEA). Fif- 
ty microliters of the cell suspensions were placed in each well contain- 
ing 50 $1 of assay medium in the presence of various concentrations 
of SPH-BSA complex and/or PMA. Control and experimental solu- 
tions both contained equivalent final concentrations of BSA and 
dimethylsulfoxide. In some case, the cell suspensions were incubated 
with SPH-BSA complex for I h at 37OC and then the treated cells 
were resuspended at IO5 cells/ml in the assay medium. Subsequently, 
the cell attachment assay was performed in the absence of SPH. The 
cells were allowed to adhere at 37OC in a humidified incubator con- 
taining 5% COZ. After 60 min, the plates were inverted to facilitate 
the removal of unbound cells, and all wells were washed with 100 $1 
PBS. Adhering cells were fixed with 2.5% glutaraldehyde for 10 min 
and stained with Giemsa. Each condition was evaluated in 
quadruplicate and the fixed cells were counted by two different in- 
vestigators in at least five microscopic fields (100x HPF) per well. 
2.4. Statistical colculatims 
Each assay described above was repeated three or four times. 
Means * SD were calculated and analyzed using Student’s t-test for 
unpaired populations. 
3. RESULTS 
3.1. Effect of S?H on ceil attachment to extracellular 
matrix proteins 
We first examined the attachment of 3LL cells to 
plastics coated with various concentrations of laminin, 
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fibronestin, or type IV collagen. The coating concentra- 
tion required to induce maximal cell binding was 
25 &ml for laminin and 10 pg/ml for fibronectin. 
3LL cells failed to bind to type IV collagen at a concen- 
tration of 10 @g/ml, as reported previously [g]. When 
the coating concentration of type IV collagen was raised 
to 100 pug/ml, the cells attached and spread on this pro- 
tein. These concentrations were therefore used in this 
study. 
We determined the attachment properties of 3LL 
cells to laminin, fibronectin, and type IV collagen in the 
presence of SPH at the concentrations ranging from 0.5 
to 10 ,&I (Fig. IA). SPH decreased the ability of 3LL 
cells to bind to laminin and type IV collagen in a dose- 
dependent manner. The concentrations of SPH re- 
quired to irnduce a 50% decrease in the attachment to 
laminin and collagen were about 5 and 1.2 ,&YI, respec- 
tively. On the other hand, attachment of the cells to 
fibronectin w8.s not inhibited by SPH at concentrations 
as high as 10,uM. To exclude the possibility that SPH 
may interact directly with these extracellular matrix 
proteins rather than the cells during the attachment 
assay, 3LL cells were preincubated with various concen- 
trations of SPH for 1 h at 37OC, and then the attach- 
ment assay was performed in the absence of SPH 
(Fig. 1B). As expected, the SPH-pretreated cells lost 
their attachment abilities to laminin and collagen in 
very much the same manner as observed in Fig. 1A. 
This indicates that the cells used in Fig. 1A had ab- 
sorbed the SPH very rapidly as observed with other cell 
lines [13,15]. 
When 3LL cells were incubated with SPH for 60 min 
at 37OC, SPH concentrations below 10pM had no ef- 
fect on cell viability, as assessed by the exclusion of 
Trypan blue dye (data not shown). When we incubated 
cells, previously exposed to 2.5 PM SPH, in SPH-free 
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Fig. I. Effect of SPH on 3LL cell attachment to laminin (a), type IV collagen (o), and fibroncctirr (I). (A) The cell attuchmcnt assuy was 
performed in the prcscncc of the indicated concentrations of SPM. (B) In order to allow more time for uptake of SPH Into 3LL cells, the ccllr 
were incubated with SPH at the concentrations ranging from 0.5 to 10 aM for I h at 37°C. After this trcattnetlt, he cell suspensions wcrc 
centrifuged lo remove SPH in the medium and the cell pellets were resuspended with KPMl 1640 containing O,lolo BSA for the uttachmcnt assay. 
* P < 0.0005 8s compared to the corresponding veluc in the absence of SPW. 
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Fig. 2. The reversibility of SPH-mediated inhibition on 3LL cell 
attachment o laminin substrate. 3LL cells were preincubated with 2.5 
or IOpM SPH for 1 h at 37°C. Subsequently, the cell attachment 
assay was performed in the absence of WM. In order to see the 
recovery of attachment abilities after the SPH treatment, the treated 
cells were further incubated for 2 hat 37°C in growth medium (RPM1 
1640 containing 109/o fetal calf serum) before the assay. Control cells 
were preincubated the same way in the absence of SPH. * P < 0.0005 
as compared to the control value. 
medium for 2 h, they completely recovered their ability 
to bind to laminin (Fig. 2): Cells that had been exposed 
to 1OpM SPM recovered only partially, from 28% 
binding to 5 1% binding. Similar results were obtained 
with collagen instead of laminin (data not shown). 
These data eliminate cytotoxicity as a factor in the in- 
hibitory effect. 
3.2. Effect of PA4A on 3EL cell attachment to luminin 
and collagen, and antagonism of the inhibition of 
SPH by PMA 
If SPH was indeed acting through the inhibition of 
PKC, PMA would presumably be able to antagonize 
the inhibitory effect of SPH on cell attachment o 
laminin and collagen, This prediction was tested in the 
following experiments. In the presence of 50 nM PMA, 
the attachment abilities of 3LL cells to laminin and col- 
lagen were significantly increased, and these increases 
were, in turn, antagonized by SPH in a dose-dependent 
manner (Fig. 3). On the other hand, attachment o 
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Pig, 4. 3LL cell attachment o laminin or type IV collagen as a function of PMA and SPH concentrations. (0) In the absence of SPH; (0) 1 pM 
SW; (m) 2 /rM SPH. * P c 0.0025; ** P < 0,0005 as compared to the corresponding value obtained tlt cad1 PMA concentration in the absence 
of SPH. 
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Fig. 3. Effect of PMA and/or SPH on 3LL cell attachment to 
laminin, type IV collagen and fibronectin substrates. The cell 
attachment assay was performed in the presence of PMA (50 nM) 
and/or the indicated concentration of SPH. * P < 0.0005 as 
compared to the value in the absence of PMA and SPH. 
fibronectin was not affected appreciably by either PMA 
or SPH. 
The nature of this antagonism was further in- 
vestigated by examining the SPH inhibition of cell at- 
tachment o laminin and collagen over a range of PMA 
concentrations (Fig. 4). PMA increased the ability of 
3LL cells to bind to laminin by 40% at 170 nM. Further 
stimulation was not seen with higher PM,4 concentra- 
tions (data not shown). The half-maximally effective 
dose of PMA for laminin was -33 nM (curves with 
solid circles). For collagen, the half-maximal dose was 
-2.5 nM (curves with solid circles). Maximal stimula- 
tion by PMA, an increase of -2OO%, was obtained at 
-5 nM. In all cases, increasing concentrations of SPH 
caused a progressive shift in the PMA dose/response 
curves to the right, suggesting that there is a competitive 
mode of antagonism between PMA and SPH. 
4. DISCUSSION 
Our data presented here show for the first time that 
SPH inhibits the attachment of 3LL cells to laminin and 
type IV collagen in a reversible and dose-dependent 
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manner. The inhibition exhibits selectivity, because 
SPH had little or no effect on attachment to fibronec- 
tin. In addition, PMA selectively enhanced attachment 
of 3LL cells to iaminin and collagen, and SPH- 
mediated inhibition of attashment to both proteins was 
competitively antagonized by PMA, suggesting the 
direct interaction of SPH with PKC. 
A possible involvement of PKC in mediation of cell 
attachment o extracellular matrix proteins has been 
suggested. For example, it has been reported that PMA 
quickly enhanced attachment of macrophages to 
laminin but not to fibronectin [161. PMA also enhanced 
the attachment of NIH/3T3 cells to laminin and type IV 
collagen, but not to fibronectin [17]. Moreover, PMA 
stimulation of human neutrophils resulted in a massive 
translocation of laminin receptors from an intracellular 
compartment to the cell surface [IS]. Recently, Shaw et 
al. demonstrated that the a6,& integrin complex func- 
tions as a macrophage laminin receptor and that PMA- 
dependent adhesion to laminin was mediated by 
phosphorylation of the a6 subunit [ 191. These observa- 
tions suggest that the functions of laminin and collagen 
receptors on tbe cell surface are regulated by PKC, and 
that protein phosphorylation including these receptor 
proteins is probably an initial event in the process of cell 
adhesion. However, the possibility cannot be ruled out 
that phosphorylation of cytoskeletal proteins such as 
vinculin and talin by PKC may affect their interaction 
with receptors for extracellular matrix proteins so as to 
change the affinity and/or specificity of the receptors 
[20-223. 
Our findings suggest that SPH may be one of the en- 
dogenous factors that regulate cell attachment o 
laminin and collagen mediated through PKC. However, 
the actual biochemical mechanism(s) remains to be 
elucidated. Study of the effect of SPH on phosphoryla- 
tion of cell surface receptors for these extracellular 
matrix proteins and its role in the receptor functions is 
of immediate interest. A complicating factor in inter- 
preting PMA experiments arises from the many reports 
of additional effects beyond the PKC stimulation and 
down-regulation. One effect of PMA is to stimulate the 
synthesis of glucosylceramide and higher glycosphin- 
golipids [23] and that of sphingomyelin (241, PMA has 
also been found to speed the conversion of sphinganine 
to ceramide [25], so it could neutralize the effect of 
SPH by lowering the intracellular concentration. If one 
speculates further, since SPH is rapidly metabolized to 
dimethyl-SPH [26] or SPH-l-phosphate [27], it might 
also be possible that the observed effects are due not to 
free SPH, but to one of these metabolic products, 
Recent work has shown that metastatic tumor cells 
have increased affinity to laminin and collagen, sug- 
gesting a major role of these proteins and their recep- 
tors in tumor metastasis [l-6,28], In fact, the highly 
metastatic lone of 3LL, the H59 cell line, was highly 
adherent o laminin compared to the parental one [28], 
42 
Thus, the affinity toward laminin of this cell line ap- 
pears to be correlated irectly with its metastatic poten- 
tial as well as in the other cell lines [a]. Moreover, it has 
been reported that the treatment of a weakly metastatic 
clone of 3LL, the P29 cell line, with PMA resulted in a 
marked increase in the ability to form lung tumor 
nodules after i.v. inoculation of the treated cells [29]. 
Together with the results of our present and previous 
reports [7-91, the accumulation of sphingoid bases, 
which was caused by the inhibition of glucosylceramide 
synthase with D-PDMP, may result in the inhibition of 
cell attachment to laminin and/or collagen and that of 
experimental metastasis. 
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